Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX&#8482;) in healthy infants, children, and adolescents.

Paradis, Erin M; Tikhonov, Oleg; Cao, Xin; Kharit, Susanna M; Fokin, Aleksandr; Platt, Heather L; Wittke, Frederick; Jotterand, Veronika

Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents.

Paradis, Erin M; Tikhonov, Oleg; Cao, Xin; Kharit, Susanna M; Fokin, Aleksandr; Platt, Heather L; Wittke, Frederick; Jotterand, Veronika.

Affiliation

Paradis EM; Merck & Co., Inc., Kenilworth, NJ, USA.
Tikhonov O; MSD, Moscow, Russia.
Cao X; Merck & Co., Inc., Kenilworth, NJ, USA.
Kharit SM; Scientific Research Institute of Children's Infections of the Russian Federal Biomedical Agency, St. Petersburg, Russia.
Fokin A; MSD, Moscow, Russia.
Platt HL; Merck & Co., Inc., Kenilworth, NJ, USA.
Wittke F; MSD, Lucerne, Switzerland.
Jotterand V; MSD, Lucerne, Switzerland.

Hum Vaccin Immunother ; 17(11): 4183-4189, 2021 11 02.

Article in En | MEDLINE | ID: mdl-34702124

Subject(s)

Chickenpox Vaccine; Chickenpox; Adolescent; Antibodies, Viral; Chickenpox/prevention & control; Chickenpox Vaccine/adverse effects; Herpesvirus 3, Human; Humans; Immunogenicity, Vaccine; Vaccines, Attenuated

Key words

Phase 3; Russia; VARIVAX™; Varicella vaccine; adolescents; chickenpox; children; immunogenicity; pediatric; safety

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chickenpox / Chickenpox Vaccine Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Humans Language: En Journal: Hum Vaccin Immunother Year: 2021 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google